A GLP-1 that seems to stop working is often linked to a normal weight-loss plateau, an incomplete dose increase, a missed or incorrectly administered dose, a storage problem, or another health or medication-related factor.

If your appetite has returned, your weight loss has stalled, or your blood sugar is rising, do not increase the dose, take extra medication, or combine GLP-1 products without speaking with your prescriber.

Common Reasons a GLP-1 Seems to Stop Working

What you notice Possible explanation What to do
Your weight has stopped changing A normal plateau or water-weight fluctuation Review several weeks of trends instead of one or two weigh-ins
Your hunger has returned Your body may have adapted, or your dose may still be increasing Ask your prescriber whether your dose and treatment plan are right for you
Your blood sugar is higher Missed doses, illness, stress, another medicine, or inadequate diabetes treatment Check your glucose as directed and contact your diabetes clinician
You recently changed products Medicines, strengths, formulations, and compounded concentrations may not be equivalent Confirm the exact product and dose with your pharmacist
You take oral semaglutide Food, drinks, or other pills taken too soon can reduce absorption Follow the empty-stomach instructions precisely

1. You May Have Reached a Normal Weight-Loss Plateau

A weight-loss plateau is a common reason the medication may seem less effective. As your body weight decreases, your body generally uses fewer calories. The calorie deficit that produced early weight loss may no longer produce the same rate of loss. Appetite can also increase after weight loss, which may offset some of the medication's appetite-reducing effect.

A stable scale does not necessarily mean the medication has stopped helping. You may still be maintaining weight loss, feeling less hunger than before treatment, or seeing better blood glucose control.

Review:

  • Your average weight over several weeks
  • Your waist measurement and clothing fit
  • Hunger and portion sizes
  • Blood glucose or A1C, if you have diabetes
  • Physical activity, sleep, alcohol, and liquid calories
  • Recent changes to your health or medication

2. You May Not Be at the Effective Maintenance Dose Yet

Most injectable GLP-1 medicines use gradual dose escalation. Semaglutide products such as Wegovy and Ozempic, along with tirzepatide products such as Zepbound and Mounjaro, start at lower doses before moving toward maintenance doses. Lower doses may be used mainly to improve tolerability while your body adjusts.

It may be too early to judge the full effect if you recently started treatment, reduced your dose, or stayed at a lower dose because of nausea or another side effect.

Your prescriber may review:

  • Your current dose and how long you have taken it
  • Whether doses were increased at the intended intervals
  • Your side effects and whether you can tolerate a higher dose
  • Whether another medication may be more suitable

Do not increase your dose faster than prescribed. Rapid titration can worsen gastrointestinal side effects and may be dangerous, particularly with compounded products.

3. A Dose May Have Been Missed or Given Incorrectly

A late, missed, partially delivered, or incorrectly measured dose can make the medication seem less effective. Check whether:

  • You missed or delayed a recent injection
  • The pen activated fully
  • Medication leaked onto your skin
  • You followed the product's injection instructions
  • You used the correct strength
  • You changed the injection day or schedule by mistake

If you use compounded semaglutide or tirzepatide in a vial, confirm all four of these details:

  1. The prescribed dose in milligrams
  2. The concentration in milligrams per milliliter
  3. The syringe measurement
  4. The product and strength listed on the label

The FDA has reported dosing errors linked to confusion between milligrams, milliliters, and "units." Some errors caused patients to take several times the intended dose and require medical attention.

Do not guess the conversion or take an additional dose to compensate.

4. Oral Semaglutide May Not Be Absorbed Properly

If you take Rybelsus, the timing of each tablet matters. The FDA-approved instructions state that you should take Rybelsus in the morning on an empty stomach with no more than 4 ounces of water. Wait at least 30 minutes before eating, drinking other beverages, or taking other oral medicines. If you miss a tablet, skip it rather than taking two doses.

Taking Rybelsus with food, coffee, supplements, or other medication can reduce the amount of semaglutide your body absorbs.

5. The Product May Have Been Stored Improperly or May Not Be What You Think

Check the medication label, expiration date, pharmacy, and storage instructions. Problems are more likely if the medication was exposed to unsuitable temperatures, arrived warm, or came from an unverified source.

Compounded GLP-1 products are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before marketing. The agency has also reported concerns about varying concentrations, incorrect labels, counterfeit products, and products that arrived warm or without adequate cooling.

If you use a compounded product, contact the dispensing pharmacy or prescribing clinic before your next dose. Ask them to verify:

  1. The exact active ingredient
  2. The concentration
  3. The dose in milligrams
  4. The syringe measurement
  5. The storage and expiration instructions

6. Another Medicine or Health Problem May Be Affecting Your Weight or Glucose

Sleep disruption, stress, illness, reduced activity, menopause-related changes, and other medicines can affect weight and blood sugar. Medicines associated with weight gain can include corticosteroids, some antidepressants, some antipsychotic medicines, insulin, sulfonylureas, and certain blood-pressure medicines.

A clinician may also assess thyroid disease, depression, binge-eating disorder, sleep apnea, or poorly controlled diabetes. These possibilities deserve attention if your appetite, weight, or glucose changed suddenly.

When Should You Contact Your Prescriber?

Contact your prescriber if:

  • Your weight or appetite has worsened for several weeks
  • Your blood sugar is consistently above your usual target
  • You have missed multiple doses
  • You are unsure how much medication you received
  • You changed pharmacies, products, or formulations
  • You have not achieved meaningful weight loss after an appropriate trial at the full prescribed dose

The National Institute of Diabetes and Digestive and Kidney Diseases states that a clinician will often reconsider treatment if a person has not lost at least 5% of their starting weight after 12 weeks on the full dose of a weight-management medication. The next step may include changing medication or addressing another cause of weight gain.

Seek Urgent Medical Care for These Symptoms

Seek urgent help for severe or persistent abdominal pain, repeated vomiting, inability to keep fluids down, severe dehydration, facial or throat swelling, or trouble breathing. GLP-1 medicines can rarely be associated with serious gastrointestinal reactions, pancreatitis, gallbladder problems, dehydration, or allergic reactions.

If you have diabetes, go to the emergency department if your blood sugar stays at or above 300 mg/dL, or if you have ketones, fruity-smelling breath, vomiting, stomach pain, trouble breathing, or confusion. These can be signs of diabetic ketoacidosis.

When you contact your prescriber, provide your exact product name, dose, injection date, recent glucose readings or weight trend, missed doses, side effects, and other medications. This information can help separate a normal plateau from an underdose, administration problem, or medical issue.